Viridian Therapeutics (VRDN) is up 5.0%, or $1.61 to $33.92.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRDN:
- Viridian Therapeutics: Positioned for Growth with Promising Pipeline and Strong Financials
- Viridian Therapeutics initiated with an Outperform at William Blair
- Viridian Therapeutics initiated with a Buy at Truist
- Promising Developments and Market Potential Drive Buy Rating for Viridian Therapeutics
- Viridian Therapeutics Advances Toward Profitability with Strategic Moves